Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Tuesday - 29 March 2022

Tuesday, 29 March 2022

Questions (774, 775, 776, 777, 778)

David Cullinane

Question:

774. Deputy David Cullinane asked the Minister for Health the number of Covid-19-related antiviral medications purchased by the HSE; and if he will make a statement on the matter. [16522/22]

View answer

David Cullinane

Question:

775. Deputy David Cullinane asked the Minister for Health if Covid-19-related antiviral medications are being used in the healthcare system, the extent to which they are being used; and if he will make a statement on the matter. [16523/22]

View answer

David Cullinane

Question:

776. Deputy David Cullinane asked the Minister for Health when paxlovid will be available for use in Ireland; and if he will make a statement on the matter. [16524/22]

View answer

David Cullinane

Question:

777. Deputy David Cullinane asked the Minister for Health if sotrovimab is available for use in Ireland, the extent to which it is available; and if he will make a statement on the matter. [16525/22]

View answer

David Cullinane

Question:

778. Deputy David Cullinane asked the Minister for Health the number of treatments of Covid-19-related monoclonal antibodies administered in Ireland; and if he will make a statement on the matter. [16526/22]

View answer

Written answers

I propose to take Questions Nos. 774 to 778, inclusive, together.

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Question No. 775 answered with Question No. 774.
Question No. 776 answered with Question No. 774.
Question No. 777 answered with Question No. 774.
Question No. 778 answered with Question No. 774.
Top
Share